Gene: RAPGEF1
Official Full Name: Rap guanine nucleotide exchange factor 1provided by HGNC
Gene Summary: This gene encodes a human guanine nucleotide exchange factor. It transduces signals from CRK by binding the SH3 domain of CRK, and activating several members of the Ras family of GTPases. This signaling cascade that may be involved in apoptosis, integrin-mediated signal transduction, and cell transformation. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some variants has not been determined. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08785 | RAPGEF1 Knockout cell line (HeLa) | Human | RAPGEF1 | 1:3~1:6 | Negative | Online Inquiry |
KO08786 | RAPGEF1 Knockout cell line (HCT 116) | Human | RAPGEF1 | 1:2~1:4 | Negative | Online Inquiry |
KO08787 | RAPGEF1 Knockout cell line (HEK293) | Human | RAPGEF1 | 1:3~1:6 | Negative | Online Inquiry |
KO08788 | RAPGEF1 Knockout cell line (A549) | Human | RAPGEF1 | 1:3~1:4 | Negative | Online Inquiry |
RAPGEF1 Gene Knockout Cell Lines are specialized cell lines that have been genetically engineered to disrupt the expression of the RAPGEF1 gene, a critical component in the signaling pathways that regulate various cellular functions such as proliferation, differentiation, and apoptosis. These cell lines serve as powerful tools for elucidating the role of RAPGEF1 in cellular processes and its implications in pathophysiological conditions.
The primary mechanism of action for RAPGEF1 involves its role as a guanine nucleotide exchange factor (GEF) that activates RAS family small GTPases, thereby influencing downstream signaling cascades such as the MAPK pathway. By knocking out RAPGEF1, researchers can examine the resultant phenotypic changes, providing insights into how alterations in signaling pathways may lead to disease states, including cancer and metabolic disorders.
The scientific importance of these knockout cell lines lies in their utility in drug discovery and development. They provide a unique experimental platform for screening potential therapeutic agents aimed at modulating signaling pathways. Additionally, they allow for in-depth studies on the molecular mechanisms of disease, contributing to the better understanding of RAPGEF1’s role in human health.
Compared to alternative research models, such as wild-type cell lines or in vivo models, RAPGEF1 Gene Knockout Cell Lines offer researchers specific advantages, including reproducibility, ease of manipulation, and high-throughput screening capabilities. Furthermore, they minimize the confounding variables present in whole-organism studies, allowing for a focused investigation into the implications of RAPGEF1 loss.
For researchers and clinicians, the ability to study these knockout models provides actionable data that can lead to novel therapeutic strategies and insights into disease mechanisms. Our company specializes in high-quality genetic engineering services, ensuring that our RAPGEF1 Gene Knockout Cell Lines meet the rigorous standards necessary for scientific research. By choosing our product, you can confidently advance your research with reliable and relevant models tailored for innovative discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.